Core Viewpoint - The stock price of Eagle Eye Technology-B has shown a significant increase of 5.22% over the past week, indicating positive market sentiment and potential growth in the AI healthcare sector [1][2]. Price Performance - The stock price fluctuated with a range of 12.75%, closing at 12.30 HKD on February 12, 2026. Technical indicators such as the MACD histogram turned positive, and the KDJ J-line rebounded from the oversold area to 71.296, suggesting improved short-term momentum [1]. Institutional Insights - Analysts have set a target average price of 13.29 HKD for Eagle Eye Technology-B, indicating potential upside from the current price level. There is a market focus on the alignment of its AI healthcare business with policy directions [2]. Recent Events - The AI healthcare industry has gained attention from policymakers, with a special study held by the State Council on February 11, 2026, emphasizing the deepening application of "Artificial Intelligence+" across various sectors. Additionally, OpenAI launched the ChatGPTHealth feature in January 2026, validating the commercialization path for AI in healthcare and enhancing industry optimism [3].
鹰瞳科技-B股价上涨，AI医疗行业获政策关注